Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 28, 2018; 24(8): 917-928
Published online Feb 28, 2018. doi: 10.3748/wjg.v24.i8.917
Published online Feb 28, 2018. doi: 10.3748/wjg.v24.i8.917
Figure 1 Flow diagram of the enrollment process.
NAs: Nucleos(t)ide analogues; HBV: Hepatitis B virus; CKD: Chronic kidney disease.
- Citation: Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928
- URL: https://www.wjgnet.com/1007-9327/full/v24/i8/917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i8.917